SGRY moved above its 50-day moving average on October 13, 2026 date and that indicates a change from a downward trend to an upward trend. In 34 of 48 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 71%.
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on SGRY as a result. In 62 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for SGRY just turned positive on October 12, 2026. Looking at past instances where SGRY's MACD turned positive, the stock continued to rise in 30 of 44 cases over the following month. The odds of a continued upward trend are 68%.
Following a +4.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where SGRY advanced for three days, in 193 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The 50-day moving average for SGRY moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
SGRY broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SGRY entered a downward trend on September 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. SGRY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.151) is normal, around the industry mean (208.195). SGRY's P/E Ratio (2872.000) is considerably higher than the industry average of (175.456). SGRY's Projected Growth (PEG Ratio) (21.970) is very high in comparison to the industry average of (2.498). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.530) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The Moving Average Convergence Divergence (MACD) for UHS turned positive on October 14, 2026. Looking at past instances where UHS's MACD turned positive, the stock continued to rise in 32 of 43 cases over the following month. The odds of a continued upward trend are 74%.
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on UHS as a result. In 67 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
Following a +4.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where UHS advanced for three days, in 236 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The Aroon Indicator entered an Uptrend today. In 207 of 298 cases where UHS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.
The 10-day RSI Indicator for UHS moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 19 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UHS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
UHS broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.392) is normal, around the industry mean (208.195). P/E Ratio (7.244) is within average values for comparable stocks, (175.456). Projected Growth (PEG Ratio) (1.197) is also within normal values, averaging (2.498). Dividend Yield (0.004) settles around the average of (0.005) among similar stocks. P/S Ratio (0.621) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. UHS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UHS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
SGRY | UHS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 17 | 24 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 71 | |
SMR RATING 1..100 | 92 | 45 | |
PRICE GROWTH RATING 1..100 | 55 | 42 | |
P/E GROWTH RATING 1..100 | 33 | 80 | |
SEASONALITY SCORE 1..100 | 20 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UHS's Valuation (11) in the Hospital Or Nursing Management industry is significantly better than the same rating for SGRY (100). This means that UHS’s stock grew significantly faster than SGRY’s over the last 12 months.
UHS's Profit vs Risk Rating (71) in the Hospital Or Nursing Management industry is in the same range as SGRY (100). This means that UHS’s stock grew similarly to SGRY’s over the last 12 months.
UHS's SMR Rating (45) in the Hospital Or Nursing Management industry is somewhat better than the same rating for SGRY (92). This means that UHS’s stock grew somewhat faster than SGRY’s over the last 12 months.
UHS's Price Growth Rating (42) in the Hospital Or Nursing Management industry is in the same range as SGRY (55). This means that UHS’s stock grew similarly to SGRY’s over the last 12 months.
SGRY's P/E Growth Rating (33) in the Hospital Or Nursing Management industry is somewhat better than the same rating for UHS (80). This means that SGRY’s stock grew somewhat faster than UHS’s over the last 12 months.
| SGRY | UHS | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 43% |
| Stochastic ODDS (%) | 1 day ago 80% | 1 day ago 56% |
| Momentum ODDS (%) | 1 day ago 70% | 1 day ago 71% |
| MACD ODDS (%) | 1 day ago 68% | 1 day ago 74% |
| TrendWeek ODDS (%) | 1 day ago 69% | 1 day ago 68% |
| TrendMonth ODDS (%) | 1 day ago 67% | 1 day ago 69% |
| Advances ODDS (%) | 4 days ago 70% | 3 days ago 72% |
| Declines ODDS (%) | 1 day ago 79% | 18 days ago 67% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 51% |
| Aroon ODDS (%) | 6 days ago 71% | 1 day ago 69% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SGRY’s FA Score shows that 1 FA rating(s) are green while UHS’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SGRY’s TA Score shows that 4 TA indicator(s) are bullish while UHS’s TA Score has 4 bullish TA indicator(s).
SGRY (@Hospital/Nursing Management) experienced а +5.18% price change this week, while UHS (@Hospital/Nursing Management) price change was +4.37% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.69%. For the same industry, the average monthly price growth was -7.17%, and the average quarterly price growth was +16.64%.
SGRY is expected to report earnings on Nov 10, 2026.
UHS is expected to report earnings on Oct 27, 2026.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor indicates that over the last year, SGRY has been loosely correlated with ASTH. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SGRY jumps, then ASTH could also see price increases.
| Ticker / NAME | Correlation To SGRY | 1D Price Change % | ||
|---|---|---|---|---|
| SGRY | 100% | -1.08% | ||
| ASTH - SGRY | 37% Loosely correlated | -3.21% | ||
| CYH - SGRY | 34% Loosely correlated | -3.68% | ||
| THC - SGRY | 34% Loosely correlated | -2.86% | ||
| HCA - SGRY | 32% Poorly correlated | -2.06% | ||
| UHS - SGRY | 31% Poorly correlated | -1.21% | ||
More | ||||